NCT02858154View on ClinicalTrials.gov

Comparison of High Flow Nasal Cannula Therapy to Nasal Oxygen as a Treatment for Obstructive Sleep Apnea in Infants

NACompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

July 26, 2021

Study Completion Date

July 26, 2021

Conditions
Obstructive Sleep Apnea
Interventions
OTHER

HFNC

All subjects will have a 3-4 hour intervention of HFNC to test effectiveness and safety for treating OSA

OTHER

Low flow oxygen by nasal cannula

All subjects will have a 6 to 8 hours intervention during the clinically scheduled PSG of titration of oxygen by nasal cannula (standard of care) to manage sleep apnea

Trial Locations (2)

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

64108

Children's Mercy Hospital, Kansas City

All Listed Sponsors
collaborator

Children's Mercy Hospital Kansas City

OTHER

lead

Children's Hospital Medical Center, Cincinnati

OTHER

NCT02858154 - Comparison of High Flow Nasal Cannula Therapy to Nasal Oxygen as a Treatment for Obstructive Sleep Apnea in Infants | Biotech Hunter | Biotech Hunter